Skip to main content

Bromperidol maintenance in schizophrenia.

Publication ,  Journal Article
McEvoy, JP; Wilson, WH; Ban, TA; Brannen, JO; Berney, S
Published in: Pharmacopsychiatria
1982

Twenty-three patients who completed a four-week, double-blind, clinical trial of bromperidol versus haloperidol were treated with bromperidol for eight additional weeks in a continuation study. Over 87 percent of patients maintained their improved status or showed further improvement. Extrapyramidal signs were frequent, but required discontinuation of treatment in only two patients.

Duke Scholars

Published In

Pharmacopsychiatria

Publication Date

1982

Volume

15

Issue

3

Start / End Page

95 / 96
 

Citation

APA
Chicago
ICMJE
MLA
NLM
McEvoy, J. P., Wilson, W. H., Ban, T. A., Brannen, J. O., & Berney, S. (1982). Bromperidol maintenance in schizophrenia. Pharmacopsychiatria, 15(3), 95–96.
McEvoy, J. P., W. H. Wilson, T. A. Ban, J. O. Brannen, and S. Berney. “Bromperidol maintenance in schizophrenia.Pharmacopsychiatria 15, no. 3 (1982): 95–96.
McEvoy JP, Wilson WH, Ban TA, Brannen JO, Berney S. Bromperidol maintenance in schizophrenia. Pharmacopsychiatria. 1982;15(3):95–6.
McEvoy, J. P., et al. “Bromperidol maintenance in schizophrenia.Pharmacopsychiatria, vol. 15, no. 3, 1982, pp. 95–96.
McEvoy JP, Wilson WH, Ban TA, Brannen JO, Berney S. Bromperidol maintenance in schizophrenia. Pharmacopsychiatria. 1982;15(3):95–96.

Published In

Pharmacopsychiatria

Publication Date

1982

Volume

15

Issue

3

Start / End Page

95 / 96